Bright Minds Biosciences Inc. DRUG
$58.84
▼ -1.01% 24H
About
Bright Minds Biosciences Inc. is a biotechnology company specializing in the development of next-generation therapeutics for neuropsychiatric disorders. The primary focus of the company is to design serotonergic compounds that have the potential to benefit patients struggling with mental health challenges. These compou…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees26
TickerDRUG
Statistics
Market Cap$577.3M
Revenue (TTM)—
Net Income—
Net Margin—
EPS—
P/E0.28
P/S—
P/B2.73
EV/EBITDA-15.00
ROE-15.0%
Dividend Yield—
Price$58.84
Data: Twelve Data · Revenue = mcap / P/S